Invectys
Biotechnology
Paris, Fr
19 employees
- Employees
- 19
- Contacts
- 1
- Emails
- 1
Invectys Overview
- Headquarters
- Paris, Fr
- Phone Number
- Available in AeroLeads
- Website
- invectys.com
- Industry
- Biotechnology
- Employees
- 19
- Founded
- 2010
- Funding
- 8.0M
- Company Email
- Available in AeroLeads
Keywords
About Invectys
Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product. Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens.
Invectys Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Invectys Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nicolas Duthoit | Marketing & Communication | Greater Paris Metropolitan Region, France |
Email
|
| Pierre Langlade Demoyen | CEO Chez Invectys |
View
|
|
| Pierre Langlade | Président-directeur Général Chez |
View
|
Employees by Management Level
Individual contributor
6 profiles
Executive
3 profiles
VP / Head
2 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 5 | 5 | 0 |
| HR | 1 | 1 | 0 |
| Marketing | 1 | 1 | 0 |
| Finance | 1 | 1 | 0 |
Compare Similar Companies to Invectys
Cellectis
Biotechnology Research
Abivax
Biotechnology
OSE Immunotherapeutics
Biotechnology Research
Enterome
Biotechnology Research
THERAVECTYS
Biotechnology Research
Acticor Biotech
Biotechnology
PEP-Therapy
Biotechnology Research
BIOMUNEX PHARMACEUTICALS
Biotechnology Research
ONCOVITA
Biotechnology Research
Stimunity
Biotechnology